377 related articles for article (PubMed ID: 8901663)
21. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
22. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
[TBL] [Abstract][Full Text] [Related]
23. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY
Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834
[TBL] [Abstract][Full Text] [Related]
24. Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.
Fontaine ER; Viau S; Jasmin G; Dumont L
J Cardiovasc Pharmacol; 1998 Jul; 32(1):12-20. PubMed ID: 9676715
[TBL] [Abstract][Full Text] [Related]
25. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
Just A; Olson AJ; Arendshorst WJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
[TBL] [Abstract][Full Text] [Related]
26. Venous endothelin receptor function in patients with chronic heart failure.
Love MP; Haynes WG; Webb DJ; McMurray JJ
Clin Sci (Lond); 2000 Jan; 98(1):65-70. PubMed ID: 10600660
[TBL] [Abstract][Full Text] [Related]
27. ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo.
Thai TL; Arendshorst WJ
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F360-8. PubMed ID: 18524860
[TBL] [Abstract][Full Text] [Related]
28. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
29. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
[TBL] [Abstract][Full Text] [Related]
30. Endogenous endothelin generation maintains vascular tone in humans.
Webb DJ
J Hum Hypertens; 1995 Jun; 9(6):459-63. PubMed ID: 7473528
[TBL] [Abstract][Full Text] [Related]
31. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries.
Fujise K; Stacy L; Beck P; Yeh ET; Chuang A; Brock TA; Willerson JT
Circulation; 1997 Nov; 96(10):3641-6. PubMed ID: 9396466
[TBL] [Abstract][Full Text] [Related]
33. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans.
Haynes WG; Strachan FE; Gray GA; Webb DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S40-3. PubMed ID: 8587426
[TBL] [Abstract][Full Text] [Related]
34. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
Held HD; Raschak M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
[TBL] [Abstract][Full Text] [Related]
35. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
Henry PJ
Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
[TBL] [Abstract][Full Text] [Related]
36. Contribution of endogenous generation of endothelin-1 to basal vascular tone.
Haynes WG; Webb DJ
Lancet; 1994 Sep; 344(8926):852-4. PubMed ID: 7916401
[TBL] [Abstract][Full Text] [Related]
37. Endothelin-1 released by vascular smooth muscle cells enhances vascular responsiveness of rat mesenteric arterial bed exposed to high perfusion flow.
Russo D; Minutolo R; Clienti C; De Nicola L; Iodice C; Savino FA; Andreucci VE
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1119-23. PubMed ID: 10604489
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
Ferro CJ; Spratt JC; Haynes WG; Webb DJ
Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
[TBL] [Abstract][Full Text] [Related]
39. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
[TBL] [Abstract][Full Text] [Related]
40. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries.
Teerlink JR; Breu V; Sprecher U; Clozel M; Clozel JP
Circ Res; 1994 Jan; 74(1):105-14. PubMed ID: 8261583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
